Chris Koddermann of ITPRI on Changing International Psilocybin Law: Truffle Talks Episode 12

James sits down with Chris Koddermann of the International Therapeutic Psilocybin Rescheduling Initiative, or ITPRI, to discuss their new campaign to reform psilocybin laws on the world stage.

Christopher Koddermann is a Swiss-based government affairs, public policy and communications specialist with extensive experience advising clients operating in complex, highly regulated, multi-stakeholder industries. With over 20 years’ experience in politics and public affairs, Christopher has advised and represented clients on a broad range of national and global regulatory issues, including in relation to WHO proceedings.

Prior to launching his public affairs business, Koddermann Public Affairs, in 2018, Christopher held senior global government affairs and communications leadership roles in the corporate sector. A lawyer by training, he spent the early part of his career working as a political and policy advisor to various Canadian federal and provincial cabinet Ministers.

In addition to his work with ITPRI, Chris is a member of Drug Science’s Medical Psychedelics Working Group.

Find ITPRI online: http://reschedulepsilocybin.org/#/res…
On Twitter: https://twitter.com/ItpriOrg
On LinkedIn: https://www.linkedin.com/company/inte…

Follow on Instagram

Truffle ReportFollow

Truffle Report is here to bring you the best of the burgeoning #psychedelic space.

Truffle Report @Truffle_Report·

24 Feb 2022

What makes peyote unique among psychedelics?

Lophos Pharma is a #peyote focused psychedelics company co-founded by wife and husband duo Claire and Evan Stawnyczy to explore mescaline’s therapeutic potential.

Read the full interview here: http://ow.ly/kN6w50I3vzt

Reply on Twitter 1496885955512483840 Retweet on Twitter 14968859555124838405 Like on Twitter 149688595551248384010 Twitter 1496885955512483840

Truffle Report @Truffle_Report·

17 Feb 2022

The push for medical #DMT is on. Truffle Report looks at top corporate and scientific developments involving the spirit molecule from @mindmedco, @AlgernonPharma, @entheonbiomed, @SmallPharma and more.

Full article here: http://ow.ly/khee50HXOHz

#science #business #medicine

Reply on Twitter 1494349939819921413 Retweet on Twitter 14943499398199214134 Like on Twitter 14943499398199214139 Twitter 1494349939819921413

Retweet on Twitter Truffle Report Retweeted

atai Life Sciences@atai_life·

16 Feb 2022

Our CEO and Co-Founder @flobrand spoke to @amanda_siebert @Forbes to give deeper context on the significance of our donation to @MAPS and the importance of collaboration between for-profit and non-profits in tackling the #mentalhealth crisis.

See: https://www.forbes.com/sites/amandasiebert/2022/02/16/exclusive-maps-accepts-500k-donation-from-atai-life-sciences-philanthropy-arm/

Reply on Twitter 1494014479981596678 Retweet on Twitter 149401447998159667810 Like on Twitter 149401447998159667829 Twitter 1494014479981596678

Truffle Report @Truffle_Report·

16 Feb 2022

A Hawaii legislative committee has approved a bill that proposes the establishment of a working group to study the therapeutic benefits of #psilocybin by a vote of 5-0.

Read the full story here: http://ow.ly/4WWI50HWJtL

#psychedelics #healing #medicine #hawaii #legal

Reply on Twitter 1493980516252590085 Retweet on Twitter 14939805162525900853 Like on Twitter 14939805162525900857 Twitter 1493980516252590085

Retweet on Twitter Truffle Report Retweeted

Psychedelic Alpha @Psyched_Alpha·

16 Feb 2022

"Inspired by a device created by in the 1950s, the creators hope to bring free transcendental experiences to 100,000 Britons – and unite the country through communal hallucinations"

https://www.theguardian.com/artanddesign/2022/feb/16/dreamachine-unboxed-brion-gysin-jon-hopkins-assemble

Reply on Twitter 1493950676484956168 Retweet on Twitter 14939506764849561683 Like on Twitter 14939506764849561684 Twitter 1493950676484956168